218 related articles for article (PubMed ID: 15708201)
21. Application of Piagetian measures of cognition in severe Alzheimer's disease.
Sclan SG; Foster JR; Reisberg B; Franssen E; Welkowitz J
Psychiatr J Univ Ott; 1990 Nov; 15(4):221-6. PubMed ID: 2284375
[TBL] [Abstract][Full Text] [Related]
22. Executive functions deficit in mild cognitive impairment.
Traykov L; Raoux N; Latour F; Gallo L; Hanon O; Baudic S; Bayle C; Wenisch E; Remy P; Rigaud AS
Cogn Behav Neurol; 2007 Dec; 20(4):219-24. PubMed ID: 18091070
[TBL] [Abstract][Full Text] [Related]
23. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms.
Amieva H; Le Goff M; Millet X; Orgogozo JM; Pérès K; Barberger-Gateau P; Jacqmin-Gadda H; Dartigues JF
Ann Neurol; 2008 Nov; 64(5):492-8. PubMed ID: 19067364
[TBL] [Abstract][Full Text] [Related]
24. [Mild cognitive impairment and Alzheimer's disease: an investigation of the CERAD-NP test battery].
Barth S; Schönknecht P; Pantel J; Schröder J
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):568-76. PubMed ID: 16217697
[TBL] [Abstract][Full Text] [Related]
25. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
26. Progressive impairment on neuropsychological tasks in a longitudinal study of preclinical Alzheimer's disease.
Mickes L; Wixted JT; Fennema-Notestine C; Galasko D; Bondi MW; Thal LJ; Salmon DP
Neuropsychology; 2007 Nov; 21(6):696-705. PubMed ID: 17983283
[TBL] [Abstract][Full Text] [Related]
27. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
Galvin JE; Powlishta KK; Wilkins K; McKeel DW; Xiong C; Grant E; Storandt M; Morris JC
Arch Neurol; 2005 May; 62(5):758-65. PubMed ID: 15883263
[TBL] [Abstract][Full Text] [Related]
28. Is cognitive reserve applicable to epilepsy? The effect of educational level on the cognitive decline after onset of epilepsy.
Pai MC; Tsai JJ
Epilepsia; 2005; 46 Suppl 1():7-10. PubMed ID: 15816971
[TBL] [Abstract][Full Text] [Related]
29. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment.
Missonnier P; Deiber MP; Gold G; Herrmann FR; Millet P; Michon A; Fazio-Costa L; Ibañez V; Giannakopoulos P
Neuroscience; 2007 Dec; 150(2):346-56. PubMed ID: 17996378
[TBL] [Abstract][Full Text] [Related]
30. Executive function: the core feature of dementia?
Voss SE; Bullock RA
Dement Geriatr Cogn Disord; 2004; 18(2):207-16. PubMed ID: 15211077
[TBL] [Abstract][Full Text] [Related]
31. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
[TBL] [Abstract][Full Text] [Related]
32. A total score for the CERAD neuropsychological battery.
Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
[TBL] [Abstract][Full Text] [Related]
33. Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly.
Myers CE; Kluger A; Golomb J; Gluck MA; Ferris S
J Geriatr Psychiatry Neurol; 2008 Jun; 21(2):93-103. PubMed ID: 18474718
[TBL] [Abstract][Full Text] [Related]
34. Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment.
Belleville S; Chertkow H; Gauthier S
Neuropsychology; 2007 Jul; 21(4):458-69. PubMed ID: 17605579
[TBL] [Abstract][Full Text] [Related]
35. Interaction between Apolipoprotein epsilon 4 and traumatic brain injury in patients with Alzheimer's disease and Mild Cognitive Impairment.
Mauri M; Sinforiani E; Bono G; Cittadella R; Quattrone A; Boller F; Nappi G
Funct Neurol; 2006; 21(4):223-8. PubMed ID: 17367583
[TBL] [Abstract][Full Text] [Related]
36. Education delays accelerated decline on a memory test in persons who develop dementia.
Hall CB; Derby C; LeValley A; Katz MJ; Verghese J; Lipton RB
Neurology; 2007 Oct; 69(17):1657-64. PubMed ID: 17954781
[TBL] [Abstract][Full Text] [Related]
37. The characteristics of patients with uncertain/mild cognitive impairment on the Alzheimer disease assessment scale-cognitive subscale.
Pyo G; Elble RJ; Ala T; Markwell SJ
Alzheimer Dis Assoc Disord; 2006; 20(1):16-22. PubMed ID: 16493231
[TBL] [Abstract][Full Text] [Related]
38. Differentiation between mild cognitive impairment and Alzheimer's disease using the FMLL mini-battery.
Abizanda P; López-Ramos B; Romero L; Sánchez-Jurado PM; León M; Martín-Sebastiá E; López-Jiménez E
Dement Geriatr Cogn Disord; 2009; 28(2):179-86. PubMed ID: 19713701
[TBL] [Abstract][Full Text] [Related]
39. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
[TBL] [Abstract][Full Text] [Related]
40. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
Miller JM; Pliskin NH
Int J Neurosci; 2006 May; 116(5):613-27. PubMed ID: 16644521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
